Sfoglia per AUTORE
ZANNI M
Collezione AO Ordine Mauriziano

  

Items : 6

Myelodysplastic syndromes with hypocellular marrow: Clinical characteristics and evaluation of outcome in HemaSphere

2018
ASL Biella
ASL Città di Torino
ASL Asti
ASL Torino 4
ASL Torino 5
AO Cuneo
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Alessandria
ASL Novara

Santini V; Gioia D; Masiera E; Poloni A; Ferrero D; Fragasso A; Finelli C; Salvi F; Gaidano G; Oliva EN; Catarini M; Cametti G; Bonferroni M; Danise P; Tassara R; Allione B; Cilloni D; Castelli A; Centurioni R; Ciravegna G; Visani G; Musto P; Balleari E; Biale L; Capelli D; Frairia C; Galimberti S; Giaccone L; Macchi S; et alii...

Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2016 Nov 20;34(33):4015-4022. doi: 10.1200/JCO.2016.67.2980. Epub 2016 Oct 31.

2016
AO Cuneo
AOU Città della Salute di Torino
AO Ordine Mauriziano

Rambaldi A; Boschini C; Delaini F; Masciulli A; Pileri S; Tabanelli V; Bruna R; Chilosi M; Falorio S; Flenghi L; Frezzato M; Trentin L; Gini G; La Nasa G; Benedetti F; Ferreri AJ; Di Raimondo F; Castellino C; Negri G; Piccin A; Billio A; Zoli V; Zanni M; Mulé A; Corradini P; Patti C; Di Nicola M; Gritti G; Rossi A; et alii...

Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma in Annals of Hematology

2013
AO Ordine Mauriziano

Ferrero S; Monitillo L; Mantoan B; Barbero D; Genuardi E; Barbiero S; Bernocco E; Caracciolo D; Ruella M; Drandi D; Zanni M; Renna F; Lobetti Bodoni C; Gueli A; Passera R; Musto P; Boccadoro M; Tarella C; Ladetto M;

The lymphocytes to monocytes ratio identifies a patient subgroup among high risk DLBCL that may benefit from upfront intensive treatment with autograft in Haematologica

2013
AO Ordine Mauriziano

Barbui AM; Masciulli A; Scarano M; Delaini F; Rossi A; Ladetto M; Corradini P; Di Nicola M; Patty C; Mulè A; Zanni M; Zoli V; Billio A; Gallamini A; Di Raimondo F; Ferreri AJM; Benedetti F; Leoni P; Semenzato G; Frezzato M; Flenghi L; Marchioli R; Barbui T; Gianni AM; Tarella C; Cortelazzo S; Rambaldi A;

Pre-emptive rituximab-based treatment of molecular relapses in follicular and mantle cell lymphoma in Haematologica

2012
AO Ordine Mauriziano

Ferrero S; Monitillo L; Mantoan B; Barbero D; Genuardi E; Bruna R; Bernocco E; Caracciolo D; Ruella M; Drandi D; Zanni M; Gueli A; Renna F; Ghione P; Lobetti Bodoni C; Barbiero S; Musto P; Boccadoro M; Tarella C; Ladetto M;

High response rate with favorable survival projections in high-risk patients with diffuse large B-cell lymphoma (DLBCL) receiving R-CHOP-14 or early intensified chemotherapy with rituximab and autograft (R-HDS): Results of the interim analysis of a gitil prospective multicenter phase III study in Blood

2009
AO Ordine Mauriziano

Cortelazzo S; Tarella C; Gianni AM; Ladetto M; Zanni M; Corradini P; Di Nicola M; Patti C; Mulè A; Majolino I; Billio A; Gueli A; Di Raimondo F; Chiarenza A; Gallamini A; Ferreri A; Pizzolo G; Benedetti F; La Nasa G; Leoni P; Gini G; Trentin L; Rodeghiero F; Marchioli R; Barbui T; Barbui A; Rambaldi A;